MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

Search

Repligen Corp

Uždarymo kaina

SektoriusSveikatos priežiūra

149.33 0.86

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

146.36

Max

150.77

Pagrindiniai rodikliai

By Trading Economics

Pajamos

9M

15M

Pardavimai

13M

182M

Pelno marža

8.152

Darbuotojai

1,778

EBITDA

7.7M

44M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+19.03% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-10-28

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

1.6B

8.4B

Ankstesnė atidarymo kaina

148.47

Ankstesnė uždarymo kaina

149.33

Naujienos nuotaikos

By Acuity

21%

79%

38 / 371 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bearish Evidence

Repligen Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-10-15 23:25; UTC

Pagrindinės rinkos jėgos

Salesforce Rises on New FY30 Financial Targets

2025-10-15 18:52; UTC

Uždarbis
Pagrindinės rinkos jėgos

Prologis Shares Gain on Raised Outlook, Data Center Growth

2025-10-15 18:30; UTC

Įsigijimai, susijungimai, perėmimai

Constellation Software to Buy U.K.'s Tecvia Holding

2025-10-15 17:19; UTC

Įsigijimai, susijungimai, perėmimai

Drahi's Altice Rejects $20 Billion Joint Offer From Peers -- 2nd Update

2025-10-15 17:11; UTC

Įsigijimai, susijungimai, perėmimai

Anglo American, MMG Offer Concessions to EU Merger Watchdog in Nickel Deal Probe

2025-10-15 23:48; UTC

Rinkos pokalbiai

Gold Steady, Supported by Expectations of Ongoing Central Bank Purchases -- Market Talk

2025-10-15 23:38; UTC

Rinkos pokalbiai

Nikkei May Rise, Tracking Gains Across Most U.S. Equity Markets -- Market Talk

2025-10-15 22:37; UTC

Rinkos pokalbiai

Economic Stars Are Aligning for RBA -- Market Talk

2025-10-15 21:44; UTC

Uždarbis

Stock Rally Is Lifting Wealth Managers. How Much Is Charles Schwab Benefiting? -- Barrons.com

2025-10-15 20:50; UTC

Rinkos pokalbiai
Uždarbis

Financial Services Roundup: Market Talk

2025-10-15 20:44; UTC

Įsigijimai, susijungimai, perėmimai

Restaurant Brands Recommends Hldrs Do Not Tender Their Shrs to the Offer >QSR.T

2025-10-15 20:44; UTC

Įsigijimai, susijungimai, perėmimai

Restaurant Brands Notified of Unsolicited Mini-Tender Offer to Buy Shrs at $28.80/Shr

2025-10-15 20:43; UTC

Įsigijimai, susijungimai, perėmimai

Restaurant Brands Notified of Unsolicited Mini-Tender Offer by NY Stk and Bond LLC to Purchase Up to 10,000 Common Shrs >QSR.T

2025-10-15 20:34; UTC

Uždarbis

Prologis Raises Outlook as Warehouse Leasing Picks Up -- WSJ

2025-10-15 20:31; UTC

Įsigijimai, susijungimai, perėmimai

RBI Recommends Hldrs Reject NYSB's "Mini-Tender Offer"

2025-10-15 20:17; UTC

Įsigijimai, susijungimai, perėmimai

GE Vernova Stock Feill With Latest Call to Sell -- Barrons.com

2025-10-15 19:06; UTC

Uždarbis

These Stocks Are Moving the Most Today: Bank of America, Morgan Stanley, ASML, AMD, Nvidia, Bunge, Progressive, Abbott, and More -- Barrons.com

2025-10-15 19:04; UTC

Rinkos pokalbiai

Oil Futures Post Back-to-Back Losses -- Market Talk

2025-10-15 18:46; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Slip Ahead of Storage Data -- Market Talk

2025-10-15 18:23; UTC

Uždarbis

This Insurer Is the One of the Worst Stocks in the S&P 500 Today. Here's Why. -- Barrons.com

2025-10-15 17:37; UTC

Įsigijimai, susijungimai, perėmimai

Constellation Software's Harris Operating Group Enters Into Agreement To Acquire TECVIA Holding GmbH >CSU.T

2025-10-15 17:34; UTC

Rinkos pokalbiai

Oil Futures Lose Ground on Trade, Oversupply Concerns -- Market Talk

2025-10-15 16:57; UTC

Uždarbis

The Nation's Biggest Banks Are Saying the Economy Is Still Strong -- WSJ

2025-10-15 16:51; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica Doesn't Disclose Financial Details

2025-10-15 16:50; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica: RetinAI Partners With Pharmaceutical Companies, Research Organizations

2025-10-15 16:49; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica: Deal Reinforces the Group's Med-Tech Journey

2025-10-15 16:48; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica: Ikerian Specializes in Artificial Intelligence, Data Management in Eyecare

2025-10-15 16:48; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica: Ikerian Is a Health Technology Company, Operating Under the RetinAI Brand

2025-10-15 16:47; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica Buys Ikerian

2025-10-15 16:34; UTC

Rinkos pokalbiai

AMD Data Center Agreements Will Provide Big Revenue Growth -- Market Talk

Akcijų palyginimas

Kainos pokytis

Repligen Corp Prognozė

Kainos tikslas

By TipRanks

19.03% į viršų

12 mėnesių prognozė

Vidutinis 176.64 USD  19.03%

Aukščiausias 220 USD

Žemiausias 135 USD

Remiantis 17 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Repligen Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

17 ratings

13

Pirkti

4

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

125.31 / 140.7Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bearish Evidence

Vidutinės trukmės periodas

Strong Bearish Evidence

Ilgalaikis periodas

Strong Bearish Evidence

Rinkos nuotaikos

By Acuity

38 / 371 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Repligen Corp

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
help-icon Live chat